Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous vitamin K for warfarin reversal in older adults with hip fracture
2016-002354-20Phase 4Terminated
- Sponsor
- DOTT.SSA CARMELINDA RUGGIERO,ISTITUTO DI GERIATRIA E GERONTOLOGIA, UNIVERSITÃ DEGLI STUDI DI PERUGIA
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of phytomenadione in hip fracture (2 arms), sponsored by DOTT.SSA CARMELINDA RUGGIERO,ISTITUTO DI GERIATRIA E GERONTOLOGIA, UNIVERSITÃ DEGLI STUDI DI PERUGIA. Primary endpoint: Time to INR reversal. Started Jun 2021; status: terminated.
02
Drugs
phytomenadione
03
Conditions
hip fracture
Beyond the preview
Go deeper on 2016-002354-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002354-20.